458870.KQ Seers Technology

Healthcare Medical Devices KOSDAQ
22,400 KRW
Close of Oct 31, 2026
19,820 64,200
Market cap
KRW 853B
P/E
21.5x
P/B
12.48x
ROE
78.1%
Dividend yield
-
Fundamental score
1.8/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 458870.KQ undervalued?

Graham number

The Graham number of Seers Technology cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Seers Technology fundamental analysis

8 of 22 checks passed

ROE 2/2

High return on equity (78.1%), above 20%.

ROA 1/1

Return on assets (62.2%) is above the industry median (-9.3%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (159.9%) is above the industry median (-3.8%).

Revenue Growth 2/2

Revenue grew 247.0% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 192.8x against interest expense, well covered.

PE vs Market 0/1

PE (21.5x) is above the market median (11.3x).

PE vs Industry 1/1

PE (21.5x) is below the industry median (22.5x).

PBV 0/1

Price to book (12.5x) is above the industry median (3.5x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 268.2, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Seers Technology stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Seers Technology

SEERS Co., Ltd. engages in the development, manufacturing, and sales of medical devices in South Korea. It offers wearable biosensor, electrocardiographic holter analyser, thermometer, pulse oximeter, monitoring dashboard, ward managing software, mobile monitoring software, medical AI, and medical adhesive material. The company was formerly known as Seers Technology Co., LTD. The company was founded in 2009 and is headquartered in Pyeongtaek-si, South Korea.

Full company profile